Zhi-Gang Li1, Jin-Juan Li, Chang-An Sun, Yuan Jin, Wei-Wei Wu. 1. Department of Prosthodontics, The Second Affiliated Hospital of Liaoning Medical University, Shanghai Road No.49, Jinzhou, 121000, People's Republic of China, ll2h_lzg@126.com.
Abstract
OBJECTIVE: Emerging evidence has showed that interleukin-18 (IL-8) promoter polymorphisms and plasma IL-18 levels may be associated with increased risk of periodontitis, but individually published results are inconclusive. The aim of this meta-analysis was to derive a more precise estimation of these associations. METHODS: A literature search of PubMed, Cochrane Library, Embase, Web of Science, SpringerLink, China BioMedicine and China National Knowledge Infrastructure databases was conducted on articles published before April 1st, 2013. Crude odds ratio (OR) or standardized mean difference (SMD) with 95 % confidence intervals (CI) were calculated. RESULTS: Nine case-control studies were included with a total of 576 periodontitis patients and 458 healthy controls. Two common polymorphisms (-607A > C and -137G>C) in the IL-18 gene were addressed. Our meta-analysis results indicated that the C variant of IL-18 -607A>C polymorphism was associated with increased periodontitis risk (C allele vs. A allele: OR = 1.86, 95 % CI: 1.30-2.65, P = 0.001; AC+CC vs. AA: OR = 2.64, 95 % CI: 1.34-5.21, P = 0.005). There was also a significant association between the C variant of IL-18 -137G>C polymorphism and an increased periodontitis risk (C allele vs. G allele: OR = 1.47, 95 % CI: 1.13-1.91, P = 0.004; GC+CC vs. GG: OR = 1.66, 95 % CI: 1.21-2.29, P = 0.002). Furthermore, the mean levels of plasma IL-18 of periodontitis patients were also higher than those of healthy controls (SMD = 1.18, 95 % CI: 0.51-1.85, P = 0.001). CONCLUSION: The current meta-analysis suggests that IL-18 promoter polymorphisms and plasma IL-18 levels are associated with increased risk of periodontitis. IL-18 promoter polymorphisms and elevated plasma IL-18 levels may be useful biomarkers for predicting the development of periodontitis.
OBJECTIVE: Emerging evidence has showed that interleukin-18 (IL-8) promoter polymorphisms and plasma IL-18 levels may be associated with increased risk of periodontitis, but individually published results are inconclusive. The aim of this meta-analysis was to derive a more precise estimation of these associations. METHODS: A literature search of PubMed, Cochrane Library, Embase, Web of Science, SpringerLink, China BioMedicine and China National Knowledge Infrastructure databases was conducted on articles published before April 1st, 2013. Crude odds ratio (OR) or standardized mean difference (SMD) with 95 % confidence intervals (CI) were calculated. RESULTS: Nine case-control studies were included with a total of 576 periodontitispatients and 458 healthy controls. Two common polymorphisms (-607A > C and -137G>C) in the IL-18 gene were addressed. Our meta-analysis results indicated that the C variant of IL-18 -607A>C polymorphism was associated with increased periodontitis risk (C allele vs. A allele: OR = 1.86, 95 % CI: 1.30-2.65, P = 0.001; AC+CC vs. AA: OR = 2.64, 95 % CI: 1.34-5.21, P = 0.005). There was also a significant association between the C variant of IL-18 -137G>C polymorphism and an increased periodontitis risk (C allele vs. G allele: OR = 1.47, 95 % CI: 1.13-1.91, P = 0.004; GC+CC vs. GG: OR = 1.66, 95 % CI: 1.21-2.29, P = 0.002). Furthermore, the mean levels of plasma IL-18 of periodontitispatients were also higher than those of healthy controls (SMD = 1.18, 95 % CI: 0.51-1.85, P = 0.001). CONCLUSION: The current meta-analysis suggests that IL-18 promoter polymorphisms and plasma IL-18 levels are associated with increased risk of periodontitis. IL-18 promoter polymorphisms and elevated plasma IL-18 levels may be useful biomarkers for predicting the development of periodontitis.
Authors: C Plater-Zyberk; L A Joosten; M M Helsen; P Sattonnet-Roche; C Siegfried; S Alouani; F A van De Loo; P Graber; S Aloni; R Cirillo; E Lubberts; C A Dinarello; W B van Den Berg; Y Chvatchko Journal: J Clin Invest Date: 2001-12 Impact factor: 14.808
Authors: U Kalina; K Ballas; N Koyama; D Kauschat; C Miething; J Arnemann; H Martin; D Hoelzer; O G Ottmann Journal: Scand J Immunol Date: 2000-12 Impact factor: 3.487
Authors: Barbara Noack; Heike Görgens; Katrin Lorenz; Andreas Ziegler; Thomas Hoffmann; Hans Konrad Schackert Journal: J Clin Periodontol Date: 2008-10-28 Impact factor: 8.728
Authors: Kåre Buhlin; Margareta Hultin; Ola Norderyd; Lena Persson; Alan Graham Pockley; Per Rabe; Björn Klinge; Anders Gustafsson Journal: J Clin Periodontol Date: 2009-07 Impact factor: 8.728
Authors: Albertas Kriauciunas; Gediminas Zekonis; Rasa Liutkeviciene Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Date: 2021-12-13 Impact factor: 1.245
Authors: Felipe Rodolfo Pereira da Silva; Larissa Dos Santos Pessoa; Any Carolina Cardoso Guimarães Vasconcelos; Weberson de Aquino Lima; Even Herlany Pereira Alves; Daniel Fernando Pereira Vasconcelos Journal: Mol Biol Rep Date: 2017-10-13 Impact factor: 2.316
Authors: Maélson Klever da Silva; Antonio Carlos Gonçalves de Carvalho; Even Herlany Pereira Alves; Felipe Rodolfo Pereira da Silva; Larissa Dos Santos Pessoa; Daniel Fernando Pereira Vasconcelos Journal: Int J Dent Date: 2017-04-26